Popular Articles
Burdock Root

Thai HIV/AIDS Advocates Urge Increased Treatment Access For IDUs
The Thai AIDS Treatment Action Group recently called on the country to launch a comprehensive harm reduction program for injection drug users in an effort to help curb the spread of HIV, Thailand"s The Nation reports. According to the group, many IDUs are unable to access drug treatment and substation therapy because of the stigma surrounding drug use in the country. Karyn Kaplan, director of development and policy for the group, said, "Health care workers have denied many injecting drug users access to an antiviral drug and the use of methadone." Public Health Minister Witthaya Kaewparadai recently announced that the country"s harm reduction programs have helped to curb the spread of HIV among IDUs, adding that local substitution programs have reduced the number of HIV-positive IDUs and that the country needs increased support from UNAIDS for such efforts. TTAG called for the government to provide prevention and treatment options, such as substitution therapy and needle-exchange programs. The Nation reports that methadone treatment is offered at hospitals across the country as part of the national health care scheme, but many health care workers refuse to administer treatment. In addition, government treatment is offered for 45 days. Kaplan said that the government should revise its policy regarding treatment access for IDUs, as a majority of IDUs are incarcerated and living with HIV or hepatitis-C without treatment access. She called on the government to "implement the international standards of medical treatment for [IDUs], without discrimination and human rights violations" (The Nation, 5/27).
generic viagra online
Prestigious National Fellowship Awarded To University Of Miami Nurse To Improve Health Care
A national fellowship program focused on expanding the role of nurses to lead change in the U.S. health care system has been awarded to Elias Provencio-Vasquez, Ph.D., N.P., F.A.A.N., F.A.A.N.P., associate professor at the University of Miami (UM) School of Nursing and Health Studies. He is one of twenty nurses selected nationwide as a 2009 Robert Wood Johnson Foundation® (RWJF) Executive Nurse Fellow.
News of the day
Patient Enrollment Complete For Phase I/II Clinical Trial For GALNS For Morquio A Syndrome
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that patient enrollment has been completed for the Phase I/II clinical trial for BMN-110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. The company expects to report initial results in the first half of 2010.
Diagnostics

Glasgow Based BioOut Active In Flu Vaccine Testing

BioOut is a strategic partner for several of the world"s leading vaccine manufacturers. As such, BioOut is currently working with partners on projects to develop vaccines against Pandemic Influenza (Swine Flu and Avian Flu). BioOut is a forward-thinking contract testing organisation which has been inspected and approved to GMP standard by the UK MHRA. The company has wide experience of testing and releasing virus vaccine, including Pandemic and Seasonal flu, and provides the release testing of vaccine lots to meet the European Pharmacopeia release guidelines. BioOut has expertise in the handling of vaccine harvests and neutralisation of the virus lots for testing. In a relatively new innovation BioOut can offer an EP compliant alternative method to the lengthy and costly Mycoplasma test EP 2.6.1; PCR methodologies are used to detect mycoplasma, this can reduce the timelines for this test to 2 days rather than the 35 days this test would normally require and reduce costs by a factor of 4. Nexxus Scotland


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):